Overview

A Dose Ranging Study of Delayed Release Beclomethasone for Prevention of Acute Enteritis in Patients With Rectal Cancer

Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and preliminary efficacy of four doses of SGX201 in subjects with rectal cancer treated with concurrent radiation and chemotherapy.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Soligenix
Collaborator:
National Cancer Institute (NCI)
Treatments:
Beclomethasone